Penumbra Inc
Total Trades
154
Buys
0
Sells
118
Largest Trade
N/A
Insiders
10
Institutional Funds
366
Inst. Value
$1M+
Activist Filings
13
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Yuen Maggie | CFO | SELL | $500K+ | 2K | $342.30 | Mar 5, 2026 |
| Grewal Harpreet | Director | SELL | $50K–$100K | 186 | $312.64 | Jan 9, 2026 |
| Wilder Thomas | Director | SELL | $50K–$100K | 186 | $310.72 | Jan 7, 2026 |
| Bose Arani | Director | SELL | $1M+ | 15K | $308.82 | Dec 16, 2025 |
| Roberts Johanna | EVP | SELL | $50K–$100K | 300 | $300.13 | Dec 10, 2025 |
| Roberts Johanna | EVP | SELL | $100K–$500K | 600 | $294.94 | Dec 4, 2025 |
| Grewal Harpreet | Director | SELL | $15K–$50K | 100 | $292.98 | Dec 4, 2025 |
| Roberts Johanna | EVP | SELL | $500K+ | 2K | $300.06 | Nov 27, 2025 |
| Bose Arani | Director | SELL | $1M+ | 8K | $300.19 | Nov 27, 2025 |
| Bose Arani | Director | SELL | $1M+ | 8K | $290.56 | Nov 26, 2025 |
| Roberts Johanna | EVP | SELL | $100K–$500K | 600 | $266.98 | Nov 13, 2025 |
| Grewal Harpreet | Director | SELL | $15K–$50K | 186 | $227.58 | Nov 7, 2025 |
| Grewal Harpreet | Director | SELL | $50K–$100K | 186 | $272.19 | Sep 4, 2025 |
| Elsesser Adam | CEO | SELL | $1M+ | 16K | $269.65 | Sep 4, 2025 |
| Elsesser Adam | CEO | EXERCISE | $500K+ | 28K | $30.00 | Sep 4, 2025 |
| Roberts Johanna | EVP | SELL | $100K–$500K | 600 | $270.58 | Sep 4, 2025 |
| Elsesser Adam | CEO and President | EXERCISE | $500K+ | 28K | $30.00 | Aug 22, 2025 |
| Elsesser Adam | CEO and President | SELL | $1M+ | 16K | $254.53 | Aug 22, 2025 |
| Elsesser Adam | CEO and President | SELL | $1M+ | 16K | $233.16 | Jul 25, 2025 |
| Elsesser Adam | CEO and President | EXERCISE | $500K+ | 28K | $30.00 | Jul 25, 2025 |
| Elsesser Adam | CEO and President | EXERCISE | $500K+ | 28K | $30.00 | Jul 11, 2025 |
| Elsesser Adam | CEO and President | SELL | $1M+ | 16K | $243.75 | Jul 11, 2025 |
| Roberts Johanna | EVP | SELL | $100K–$500K | 600 | $252.70 | Jul 3, 2025 |
| Elsesser Adam | CEO and President | EXERCISE | $500K+ | 28K | $30.00 | Jun 28, 2025 |
| Elsesser Adam | CEO and President | SELL | $1M+ | 16K | $253.40 | Jun 28, 2025 |
| O'Rourke Bridget | Director | SELL | $1K–$15K | 50 | $259.78 | Jun 18, 2025 |
| Elsesser Adam | CEO and President | SELL | $1M+ | 16K | $253.67 | Jun 13, 2025 |
| Elsesser Adam | CEO and President | EXERCISE | $500K+ | 28K | $30.00 | Jun 13, 2025 |
| Roberts Johanna | EVP | SELL | $100K–$500K | 600 | $258.17 | Jun 4, 2025 |
| Elsesser Adam | CEO and President | EXERCISE | $500K+ | 28K | $30.00 | May 31, 2025 |
| Elsesser Adam | CEO and President | SELL | $1M+ | 16K | $267.91 | May 31, 2025 |
| Elsesser Adam | CEO and President | EXERCISE | $500K+ | 28K | $30.00 | May 16, 2025 |
| Elsesser Adam | CEO and President | SELL | $1M+ | 17K | $298.22 | May 16, 2025 |
| O'Rourke Bridget | Director | SELL | $15K–$50K | 100 | $286.15 | May 16, 2025 |
| Roberts Johanna | EVP | EXERCISE | $1K–$15K | 55 | $22.04 | May 14, 2025 |
| Roberts Johanna | EVP | SELL | $100K–$500K | 900 | $298.55 | May 14, 2025 |
| Elsesser Adam | CEO and President | SELL | $1M+ | 17K | $289.37 | May 9, 2025 |
| Elsesser Adam | CEO and President | EXERCISE | $500K+ | 28K | $30.00 | May 9, 2025 |
| Yuen Maggie | CFO | EXERCISE | $100K–$500K | 900 | $158.30 | May 6, 2025 |
| Yuen Maggie | CFO | SELL | $500K+ | 2K | $299.01 | May 6, 2025 |
| Bose Arani | Director | SELL | $1M+ | 12K | $298.73 | Apr 29, 2025 |
| Roberts Johanna | EVP | EXERCISE | $1K–$15K | 600 | $22.04 | Apr 25, 2025 |
| Roberts Johanna | EVP | SELL | $100K–$500K | 600 | $300.01 | Apr 25, 2025 |
| Elsesser Adam | CEO and President | EXERCISE | $500K+ | 28K | $30.00 | Apr 18, 2025 |
| Elsesser Adam | CEO and President | SELL | $1M+ | 17K | $274.35 | Apr 18, 2025 |
| O'Rourke Bridget | Director | SELL | $1K–$15K | 50 | $271.21 | Apr 17, 2025 |
| Elsesser Adam | CEO and President | EXERCISE | $1M+ | 41K | $30.00 | Apr 5, 2025 |
| Elsesser Adam | CEO and President | SELL | $1M+ | 17K | $272.24 | Apr 5, 2025 |
| Wilder Thomas | Director | SELL | $50K–$100K | 360 | $266.93 | Apr 5, 2025 |
| Wilder Thomas | Director | SELL | $50K–$100K | 360 | $264.58 | Apr 2, 2025 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 366 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| VANGUARD GROUP INC | 3.5M | $1M+ | SH |
| STATE STREET CORP | 1.2M | $1M+ | SH |
| Clearbridge Investments, LLC | 691K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 637K | $1M+ | SH |
| Champlain Investment Partners, LLC | 602K | $1M+ | SH |
| Capital World Investors | 426K | $1M+ | SH |
| CONGRESS ASSET MANAGEMENT CO | 382K | $1M+ | SH |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 346K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 308K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 288K | $1M+ | SH |
| BAILLIE GIFFORD & CO | 255K | $1M+ | SH |
| GOLDMAN SACHS GROUP INC | 250K | $1M+ | SH |
| Jain Global LLC | 183K | $1M+ | SH |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 174K | $1M+ | SH |
| BALYASNY ASSET MANAGEMENT L.P. | 162K | $1M+ | SH |
| ALLIANCEBERNSTEIN L.P. | 158K | $1M+ | SH |
| Baird Financial Group, Inc. | 146K | $1M+ | SH |
| PFM Health Sciences, LP | 145K | $1M+ | SH |
| Stephens Investment Management Group LLC | 121K | $1M+ | SH |
| NEW YORK STATE COMMON RETIREMENT FUND | 114K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 6, 2026
4.7%
1.8M shares
SC 13G/A · Feb 5, 2026
13.0%
5.1M shares
T. Rowe Price Associates, Inc.
SC 13G/A · Feb 14, 2025
3.3%
1.3M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Nov 14, 2024
5.1%
2.0M shares
Capital Research Global Investors 95-1411037
SC 13G/A · Nov 12, 2024
0.0%
0 shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G · Feb 14, 2024
8.0%
3.1M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
9.5%
3.7M shares
Capital Research Global Investors 95-1411037
SC 13G/A · Feb 9, 2024
6.9%
2.7M shares
SC 13G/A · Jan 24, 2024
10.4%
4.0M shares
Capital Research Global Investors 95-1411037
SC 13G/A · Feb 13, 2023
6.1%
2.3M shares
SC 13G/A · Jan 23, 2023
11.6%
4.4M shares
SC 13G/A · Oct 7, 2022
10.3%
3.9M shares
Capital Research Global Investors 95-1411037
SC 13G/A · Feb 11, 2022
7.4%
2.8M shares